J Stroke.  2022 Sep;24(3):383-389. 10.5853/jos.2021.03846.

CT- versus MRI-Based Imaging for Thrombolysis and Mechanical Thrombectomy in Ischemic Stroke: Analysis from the Austrian Stroke Registry

Affiliations
  • 1Department of Neurology, St. John’s Hospital, Vienna, Austria
  • 2Austrian National Public Health Institute/BIQG, Vienna, Austria
  • 3Research Unit of Computational Statistics, University of Technology, Vienna, Austria
  • 4Medical Faculty, Sigmund Freud University Vienna, Vienna, Austria
  • 5Department of Radiology, St. John’s Hospital, Vienna, Austria
  • 6Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria

Abstract

Background and Purpose
It is unclear whether a particular stroke imaging modality offers an advantage for the acute stroke treatment. The aim of this study was to compare procedure times, efficacy and safety of thrombolysis and/or thrombectomy based on computed tomography (CT) versus magnetic resonance imaging (MRI) acute stroke imaging.
Methods
Data of stroke patients who received intravenous thrombolysis (IVT) and/or mechanical thrombectomy (MT) were extracted from a nationwide, prospective stroke unit registry and categorized according to initial imaging modality. Study endpoints included procedure times, symptomatic intracerebral hemorrhage (sICH), early neurological improvement, 3-month functional outcome by modified Rankin Scale (mRS) and mortality.
Results
Stroke patients (n=16,799) treated with IVT and 2,248 treated with MT were included. MRI-guided patients (n=2,599) were younger, had less comorbidities and higher rates of strokes with unknown onset as compared to CT-guided patients. In patients treated with IVT, no differences were observed regarding the rates of functional outcome by mRS 0–1 (adjusted odds ratio [OR], 0.87; 95% confidence interval [CI], 0.71 to 1.05), sICH (adjusted OR, 0.82; 95% CI, 0.61 to 1.08), and mortality (adjusted OR, 0.88; 95% CI, 0.63 to 1.22). Patients undergoing MT selected by MRI as compared to CT showed equal rates of functional outcome by mRS 0–2 (adjusted OR, 0.87; 95% CI, 0.65 to 1.16), sICH (adjusted OR, 0.9; 95% CI, 0.51 to 1.69), and mortality (adjusted OR, 0.62; 95% CI, 0.35 to 1.09). MRI-guided patients showed a significant intrahospital delay of about 20 minutes in both the IVT and the MT group.
Conclusions
This large non-randomized comparison study indicates that CT- and MRI-guided patient selection for IVT/MT may perform equally well in terms of functional outcome and safety.

Keyword

Computed tomography; Magnetic resonance imaging; Thrombectomy; Thrombolysis; Outcome

Reference

References

1. Zhang XH, Liang HM. Systematic review with network meta-analysis: diagnostic values of ultrasonography, computed tomography, and magnetic resonance imaging in patients with ischemic stroke. Medicine (Baltimore). 2019; 98:e16360.
2. Köhrmann M, Jüttler E, Fiebach JB, Huttner HB, Siebert S, Schwark C, et al. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol. 2006; 5:661–667.
3. Macha K, Hoelter P, Siedler G, Knott M, Schwab S, Doerfler A, et al. Multimodal CT or MRI for IV thrombolysis in ischemic stroke with unknown time of onset. Neurology. 2020; 95:e2954–e2964.
4. Meinel TR, Kaesmacher J, Mosimann PJ, Seiffge D, Jung S, Mordasini P, et al. Association of initial imaging modality and futile recanalization after thrombectomy. Neurology. 2020; 95:e2331–e2342.
5. Provost C, Soudant M, Legrand L, Ben Hassen W, Xie Y, Soize S, et al. Magnetic resonance imaging or computed tomography before treatment in acute ischemic stroke. Stroke. 2019; 50:659–664.
6. Brainin M, Steiner M; Austrian Stroke Registry for Acute Stroke Units. Acute stroke units in Austria are being set up on a national level following evidence-based recommendations and structural quality criteria. Cerebrovasc Dis. 2003; 15 Suppl 1:29–32.
7. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 359:1317–1329.
8. Campbell BC, Parsons MW. Imaging selection for acute stroke intervention. Int J Stroke. 2018; 13:554–567.
9. Schellinger PD, Thomalla G, Fiehler J, Köhrmann M, Molina CA, Neumann-Haefelin T, et al. MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients. Stroke. 2007; 38:2640–2645.
10. Thomalla G, Boutitie F, Ma H, Koga M, Ringleb P, Schwamm LH, et al. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data. Lancet. 2020; 396:1574–1584.
11. Rotzinger DC, Mosimann PJ, Meuli RA, Maeder P, Michel P. Site and rate of occlusive disease in cervicocerebral arteries: a CT angiography study of 2209 patients with acute ischemic stroke. AJNR Am J Neuroradiol. 2017; 38:868–874.
12. Kim JT, Cho BH, Choi KH, Park MS, Kim BJ, Park JM, et al. Magnetic resonance imaging versus computed tomography angiography based selection for endovascular therapy in patients with acute ischemic stroke. Stroke. 2019; 50:365–372.
13. Ma H, Campbell BC, Parsons MW, Churilov L, Levi CR, Hsu C, et al. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. N Engl J Med. 2019; 380:1795–1803.
14. Krebs S, Posekany A, Ferrari J, Lang W, Sommer P, Gattringer T, et al. Intravenous thrombolysis in wake-up stroke: real-world data from the Austrian Stroke Unit Registry. Eur J Neurol. 2019; 26:754–759.
Full Text Links
  • JOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr